---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-138813"
form_type: "8-K"
ticker: "COGT"
cik: "0001622229"
company_name: "Cogent Biosciences, Inc."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T13:20:29.362099+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cogent Biosciences secures up to $400M non-dilutive debt facility; $50M drawn at closing

## Summary
- $400M credit facility from SLR; first tranche of $50M funded on June 11, 2025.
- Interest rate: 4.75% + greater of 1-month SOFR or 4.15%; matures June 1, 2030.
- Future tranches tied to milestones: $25M after positive SUMMIT data, $75M after positive PEAK data.
- $50M additional upon $85M net product revenue on trailing 6 months by June 30, 2027; $200M mutual.
- Proceeds for working capital; monthly interest-only until June 1, 2028, with possible deferral to 2029.

## SEC filing metadata
- accession: 0001193125-25-138813
- form_type: 8-K
- ticker: COGT
- cik: 0001622229
- company_name: Cogent Biosciences, Inc.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1622229/000119312525138813/0001193125-25-138813-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1622229/000119312525138813/d21181d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-138813
- JSON: https://secwatch.observer/filing/0001193125-25-138813.json
- Plain text: https://secwatch.observer/filing/0001193125-25-138813.txt

## Key facts
- Debt Financings
  Cogent Biosciences, Inc. incurred term loan of $50.0 million with SLR Investment Corp. at 4.75% plus the greater of (i) one-month term SOFR, and (ii) 4.15% per annum maturing June 1, 2030.
  - Instrument: term loan
  - Principal: $50.0 million
  - Counterparty: SLR Investment Corp.
  - Rate: 4.75% plus the greater of (i) one-month term SOFR, and (ii) 4.15% per annum
  - Maturity: June 1, 2030
  - Event: incurrence
  source text: Security Agreement provides for a non-dilutive term loan facility (the “Credit Facility”) of up to an aggregate principal amount of $400.0 million, of which a first tranche of $50.0 million was fully funded on the Closing Date, with future tranches at the Company’s election subject to achievement of milestones consisting of (a) a second tranche of $25.0 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1622229/000119312525138813/0001193125-25-138813-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.